This single-institution retrospective study compares the accuracy of clinical and magnetic resonance imaging (MRI) staging of cervical cancer. For patients who underwent surgery, MRI and clinical staging were compared to final pathological stage. Pathological stage was utilised as the reference standard.
Introduction
Cervical cancer is a common malignancy in developing countries, in particular those with a high prevalence of human papillomavirus and human immunodeficiency virus (HIV). 1 According to the South African National Cancer Registry's 2001 published report, cervical cancer was the third most common malignancy (16%) after breast cancer (19%) and basal cell carcinoma of the skin (17%) in female patients, and the most common malignancy in black African women (31%). 2 Approximately 250 patients are seen every year with newly diagnosed cervical cancer at our institution. The majority present with locally advanced and inoperable disease, owing in part to a lack of awareness of screening programmes, especially in the poorer socioeconomic groups. Only 40-50 patients are suitable for surgical treatment per year.
A multidisciplinary team, consisting of a radiation oncologist, as well as a member of the gynaecology oncology team, evaluates all new patients. Patients are staged using the International Federation of Gynecology and Obstetrics (FIGO) clinical classification. 3 The FIGO clinical staging remains the gold standard and subsequent surgical findings do not impact on the final recorded stage. In addition to a clinical examination, use is made of radiological investigations, which include a chest radiograph, a pelvic and abdominal ultrasound, and computed tomography (CT) or magnetic resonance imaging (MRI).
The two main treatment modalities in cervical cancer are surgery and primary chemoradiation (CRT). Options regarding treatment depend upon the stage of the patient, fertility plans and underlying medical conditions. Accurate staging is crucial for appropriate treatment selection. The aim is to avoid having to use bimodality treatment in the early-stage group (surgery followed by CRT), as it is associated with greater acute toxicity and late morbidity, compared to singlemodality treatment. [4] [5] [6] [7] In an effort to more accurately stage patients, the use of CT Table I . The majority of patients were clinically staged as IBi. The majority of patients staged by MRI were IIB. Data demonstrated that the clinical examination had a higher specificity than MRI staging and a superior PPV in our small cohort. By contrast, MRI staging had an improved sensitivity in comparison to clinical staging. The NPV was comparable between the two staging methods (Table IV and V) . The identification of pathological lymphadenopathy had a sensitivity of 0% and a specificity of 100%, with a PPV of 0% and a NPV of 80% (CI: 68.3-91.7%) as seen in Table IV and V. The reason for this is unclear as the same criteria were used at our institute as described in the literature to define a pathological node (10 mm). ³
Discussion
Our small cohort study shows that in the surgical group of patients, there was limited concordance between MRI staging and pathological stage and a large percentage were inaccurately staged by MRI. This is in contrast to the literature, where a review by Boss et al showed that a change to an earlier stage occurred infrequently following MRI, in the region of 10-15%. 8 The ORs for the accuracy of clinical staging and MRI staging were not significantly different in this study.
There are multiple variables that might influence the accuracy of MRI reporting, for example, not having a dedicated radiologist to report pelvic MRIs and the difference in level of experience of individual consultants within the department. Further pitfalls leading to staging errors with MRI include difficulties in differentiating foci of cancer from surrounding tissue oedema, and excluding vaginal involvement in the presence of a bulky tumour.
In the group of patients who did not undergo surgery, it was found that there was limited agreement between the clinical stage and MRI stage. The treatment decision was changed in a third of patients, based on the result of the MRI. Compared to the literature, in their study population, Stenstedt et al found that treatment decisions were altered in only 8% of patients, based on the results of the MRI. 9 Imaging with MRI and the resultant change in clinical stage could potentially spare this population of patients the toxicity of bimodality treatment. However, following the results of this study, we questioned whether or not, in our cohort, some patients might have been inaccurately "upstaged". This assumption is based on the results of the analysis that the sensitivity for MRI in detecting parametrial involvement was at least 80%.
The sensitivity and PPV for parametrial involvement and vaginal involvement reported by MRI in our cohort of patients was also lower than that reported by Sheu et al, but the NPV was more comparable. 10 It would appear that MRI inaccurately overstaged disease in some of our patients, but it is difficult to draw a conclusion based on the large CIs. A reason for this is the small study population. The lower sensitivity and PPV of MRI detection of lymphadenopathy was clearly evident in our cohort, compared to the findings of both Shue et al and Hricak et al. 10, 11 This may be because of the fact that MRI is only able to evaluate pathologically enlarged nodes ≥ 1 cm in size, whereas surgically positive nodes may have a small microscopic focus. Once again, these parameters are potentially inaccurate as demonstrated by the large CIs.
The comparison of clinical, with pathological, staging, in our cohort of patients showed there was a 43.9% concurrence. This value is lower than that reported by Boss et al. 8 Hricak et al reported higher accuracy for clinical staging, but the authors suggested that this was because of the fact that in 85% of patients, final staging was only documented after the radiology findings were reported. 11 They reported a 100% PPV for parametrial involvement and 92.3% NPV for vaginal involvement. This is contrary to most findings in the literature, where clinical staging was generally poor. When comparing MRI staging versus surgical stage, and clinical staging versus surgical stage, there appears to be a trend in our institution to show that clinical staging was more accurate than MRI in detecting parametrial and vaginal involvement. In addition, the specificity values of clinical staging were higher than MRI staging in our cohort. The German group of Hancke et al reported results similar to our own findings: that clinical staging was superior to MRI. 12 However, the majority of published studies found this not to be the case.
At the 45 th annual meeting of the American Society of Clinical Oncology, the complexity of oncological care was discussed and recommendations presented that cancer care requires interdisciplinary collaboration that is provided through the development of multidisciplinary teams. 13 The multidisciplinary forum provides members of the patient care team with the opportunity to discuss face-to-face clinical, pathological and radiological findings, decide on the stage of the patient disease and devise an appropriate treatment plan that is relevant to the patient's situation. All major international centres have a dedicated radiologist for pelvic MRI interpretation as part of the multidisciplinary team.
Following the completion of our study, we recommend that there should be a dedicated radiologist on the multidisciplinary team for pelvic MRI. This will lead to consistency and most likely improved accuracy in reporting MRIs.
The strengths of this study include the fact that all patient data were available for those who met the inclusion criteria. Furthermore, there was a long study period during which experienced surgical and radiotherapy clinicians were consistent. Limitations include the small number of patients with earlystage cervical cancer who underwent surgery. As a consequence of the small study population, multivariate and univariate analysis could not be performed.
Results of this cohort study suggest a trend that clinical staging is more accurate than MRI staging. The international literature supports the hypothesis that MRI is the more accurate staging modality, rather than clinical staging. As stated above, the use of MRI at our institution had a number of limitations, which may have many commonalities with other resourceconstrained institutions.
